2013-06-04 14:28:38 UTC

Current Celiac Disease Screening Strategy Proves Cost Effective in Preventing Bone Diseases

June 4, 2013

KT Park and colleagues report in Clinical Gastroenterology and Hepatology that universal serologic screening and symptomatic at-risk screening (SAS) are similar in lifetime costs and quality of life, although the current SAS strategy is overall more cost-effective in preventing bone loss and fractures among patients with undiagnosed or subclinical disease.

Patients with asymptomatic or poorly managed celiac disease can experience bone loss, placing them at risk for hip and vertebral fractures. KT Park and colleagues analyzed the cost-effectiveness of universal serologic screening (USS) versus symptomatic at-risk screening (SAS) strategies for celiac disease because of the risk of non-traumatic hip and vertebral fractures if untreated or undiagnosed. They report in Clinical Gastroenterology and Hepatology that USS and SAS are similar in lifetime costs and quality of life, although the current SAS strategy was overall more cost-effective in preventing bone loss and fractures among patients with undiagnosed or subclinical disease. On the basis of best available supportive evidence, it is more cost-effective to maintain the standard celiac screening practices, although future robust population-based evidence in other health outcomes could be leveraged to reevaluate current screening guidelines.

Clinical Gastroenterology and Hepatology 2013: 11(6), 645-653

More on Celiac Disease

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Avoidance of Cow's Milk–Based Formula for At-Risk Infants Does Not Reduce Development of Celiac Disease: A Randomized Controlled Trial

Oct. 1, 2017

Increased cow's milk antibody titers before the appearance of anti-TG2A and celiac disease indicates that subjects with celiac disease might have increased intestinal permeability in early life.

Can You Name the Top Five Products with Gluten?

Sept. 20, 2017

This month’s CGH patient education section provides you with top talking points for your celiac disease patients.